First, PYCR1 knockdown has been shown to inhibit proliferation, drug resistance and EMT by affecting the STAT3-mediated p38 MAPK and NF-κB pathways in colorectal cancer cells46,47. This evidence concerns the gene STAT3 and colorectal cancer.